EN DE

Gasporox AB (GPX) Fair Value & Analysis

Technology · SE · Market cap 68.3M SEK

GA Gasporox AB GPX · ST
Pricekr 6.75
Fair Valuekr 1.42
Upside-79.0%
Quality21/100
Watch Gasporox AB for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -11.5% net margin
Moderate debt · negative free cash flow
Trails peers (3/10)
Narrow moat 10/100
Evidence: Low Range kr 1.06 – kr 2.12 Share as image

Fair value as of: Jul 18, 2026

From 1 valuation models · updated 23 days ago

Share price −0.7% over the past month.

Below-average quality, and screening another 79% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (kr 2.12). The favourable scenario is already priced in.
  • Weak quality (21/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • A fairly wide model range (kr 1.06 to kr 2.12) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

kr 20.00 kr 6.10 Fair Value kr 1.42 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.

How to read this chart

60‑month range kr 6.10 – kr 20.00 · fair‑value band kr 1.06 – kr 2.12 · the kr 6.75 price screens above the kr 1.42 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 18, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Gasporox AB (GPX) currently trades at kr 6.75, while our model-based Fair Value estimate is kr 1.42, implying the stock looks roughly 79.0% overvalued today. The Quality Score stands at 21/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Gasporox AB generated revenue of 36.8M SEK at a net margin of -21.0%. Revenue grew 29.0% year over year. It earns a return on equity of -33.1%. The balance sheet holds a net cash position of 6.7M SEK. Fundamentals as of Jul 18, 2026

Our scenario range runs from kr 1.06 (bear case) to kr 2.12 (bull case); at kr 6.75, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 32% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -45% fair-value upside, at -79%, GPX screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) kr 1.06 kr 1.42 kr 2.12 50
All 1 models by family
Asset-Based
NCAV (Graham) kr 1.06 kr 1.42 kr 2.12 50

Notify me when GPX reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 36.8M SEK
Revenue growth (YoY) +29.0%
Net margin -21.0%
Return on equity -33.1%
Free cash flow −4.7M SEK FY2025
Operating margin 11.4%
More key figures
EPS (TTM) kr -0.5000
EPS growth (YoY) -98.7%
Net cash 6.7M SEK FY2025

Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 21/100

Of which business quality 23 · Market factors (momentum, volatility) 24

Profitability 8
Margins and returns on capital today
Quality Growth 2
Are margins and returns improving?
Cashflow 3
Earnings quality: real cash, not paper profit
Fin. Strength 40
Balance sheet, leverage, solvency risk
Investment 69
Disciplined investing over empire-building
Low Volatility 40
Calm price path (market factor)
Momentum 22
Price trend over the last 3–12 months (market factor)
52W Momentum 9
Distance to the 52-week high (market factor)
Net Issuance 35
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software.

Full company description

Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha studies, multi-parameter analysis, batch check, stability studies, and customer defined studies; and IQ/OQ protocols, remote calibration services, training, and customized accessories for the GPX1500. Gasporox AB (publ) was incorporated in 2005 and is based in Lund, Sweden.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Gasporox AB reported revenue of kr 31.6M in FY2025 versus kr 15.7M in FY2021, a compound +19.0%/yr. Reported net income was −kr 7.7M in FY2025.

Growth Quality 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
31.6M SEK
Latest YoY
−7.4%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+20.5%
Avg. growth/yr (12Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+44.4%
Revenue +19.0%/yr
FY21 kr 15.7M
FY22 kr 21.4M
FY23 kr 31.4M
FY24 kr 34.1M
FY25 kr 31.6M
Net income
FY21 −kr 5.4M
FY22 −kr 4.6M
FY23 −kr 1.2M
FY24 −kr 2.7M
FY25 −kr 7.7M

GPX screens 79% overvalued. Compare with Keysight Technologies, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Gasporox AB Fair Value". https://www.fairvalue-calculator.com/stock/GPX

Peer Group

Scientific & Technical Instruments · 161 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 23 · Bottom 25%
Fair Value upside −79% · Bottom 25%
Return on assets -4% · Bottom 25%
Net margin (TTM) -11% · Bottom 25%
Operating margin (TTM) -11% · Bottom 25%
Revenue growth 94% · Top 25%
Debt / equity 0.73× · Higher than 75% of peers

Valuation Multiples vs Scientific & Technical Instruments median · lower = cheaper

P/B 0.36× · Cheaper than 75% of peers
P/S (TTM) 0.17× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 100 · sector 34
PAST 0 · sector 25
HEALTH 64 · sector 98
DIVIDEND 0 · sector 24

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
Keysight Technologies, Inc KEYS $315.90 $84.16 -73%
Garmin Ltd GRMN $241.76 $146.67 -39%
Teledyne Technologies Incorporated TDY $635.52 $367.58 -42%
Chroma ATE Inc 2360 1,905 TWD 286.15 TWD -85%
Hexagon AB HEXAB kr 80.10 kr 52.93 -34%
MKS Inc MKSI $324.69 $77.46 -76%
AVIC Chengdu Aircraft Company 302132 ¥52.91 ¥34.47 -35%
Fortive Corporation FTV $61.78 $33.84 -45%
Trimble Inc TRMB $52.72 $24.47 -54%
Cognex Corporation CGNX $64.07 $13.75 -79%

Compare Gasporox AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Gasporox AB (GPX) overvalued or undervalued?
As of Jul 18, 2026, our model estimates a fair value of kr 1.42 versus a price of kr 6.75, about −79% (overvalued).
What is the fair value of GPX?
Our model-based fair value for Gasporox AB is kr 1.42 (as of Jul 18, 2026), built from audited fundamentals. The current price is kr 6.75.
What is the quality score of GPX?
Gasporox AB has a Quality Score of 21/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Gasporox AB (GPX)?
Gasporox AB reported trailing-twelve-month revenue of about 36.8M SEK (latest available figure, as of Jul 18, 2026).
What is the net profit margin of GPX?
The net profit margin of Gasporox AB is about -21.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Gasporox AB and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.